Dysplasia

10 drugs in development·9 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
garetosmab	REGENERON PHARMACEUTICALS, INC. (REGN) Analyze with AI →
surfactant	GH Research PLC (GHRS) Analyze with AI →

Phase 2(5)

Drug	Company
blu-782	Blueprint Medicines Corp (BPMC) Analyze with AI →
incb000928	Incyte Corp. (INCY) Analyze with AI →
intravenous immunoglobulin	HWH International Inc. (HWH) Analyze with AI →
ipn60130	CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) Analyze with AI →
sar442501	Sanofi (SNY) Analyze with AI →

Preclinical(1)

Drug	Company
hcw11-040	HCW Biologics Inc. (HCWB) Analyze with AI →

Phase 1/Phase 2(2)

Drug	Company
pth-ia	GH Research PLC (GHRS) Analyze with AI →
pth-ia	National Research Corporation Common Stock (Delaware) (NRC) Analyze with AI →

BioSniper tracks 10 drugs in development for Dysplasia across 9 companies.

There are 1 clinical trial targeting Dysplasia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.